Jane Street Group, LLC Brainstorm Cell Therapeutics Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.92 - $4.19 $56,356 - $80,867	-19,300 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$3.14 - $4.09 $4,082 - $5,317	-1,300 Reduced 6.31%	19,300 $64,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $86,086 - $114,686	-28,600 Reduced 58.13%	20,600 $78,000
Q1 2021 May 18, 2021	SELL	$3.46 - $7.88 $328,008 - $747,024	-94,800 Reduced 65.83%	49,200 $188,000
Q4 2020 Feb 17, 2021	SELL	$3.99 - $17.73 $220,647 - $980,469	-55,300 Reduced 27.75%	144,000 $652,000
Q3 2020 Nov 17, 2020	BUY	$11.19 - $16.92 $596,427 - $901,836	53,300 Added 36.51%	199,300 $3.37 Million
Q2 2020 Aug 17, 2020	BUY	$4.42 - $12.66 $503,438 - $1.44 Million	113,900 Added 354.83%	146,000 $1.64 Million
Q1 2020 May 15, 2020	BUY	$4.01 - $8.88 $128,721 - $285,048	32,100 New	32,100 $149,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.